Skip to search.
 TSX Up 2.43% TSX Ventures Up 0.55%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
70.08 Up 2.82(4.19%) Feb 12, 4:00PM EST
|After Hours : 70.00 Down 0.08 (0.11%) Feb 12, 5:58PM EST
Prev Close:67.26
Open:68.00
Bid:67.94 x 200
Ask:78.13 x 200
1y Target Est:132.72
Beta:1.7992
Next Earnings Date:25-Feb-16BMRN Earnings announcement
Day's Range:67.07 - 71.25
52wk Range:62.12 - 151.75
Volume:2,156,307
Avg Vol (3m):1,690,160
Market Cap:11.30B
P/E (ttm):N/A
EPS (ttm):-1.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 4.19%11.30B
FOLDUp 1.72%666.39M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.63
Quarterly EPS Est (Dec-15) :0.67
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-4.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback